Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1993 Jun;52(6):1094–1101.

Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

A Sibille 1, C M Eng 1, S J Kim 1, G Pastores 1, G A Grabowski 1
PMCID: PMC1682271  PMID: 8503443

Abstract

Gaucher disease is the most frequent lysosomal storage disease and the most prevalent genetic disease among Ashkenazi Jews. Gaucher disease type 1 is characterized by marked variability of the phenotype and by the absence of neuronopathic involvement. To test the hypothesis that this phenotypic variability was due to genetic compounds of several different mutant alleles, 161 symptomatic patients with Gaucher disease type 1 (> 90% Ashkenazi Jewish) were analyzed for clinical involvement, and their genotypes were determined. Qualitative and quantitative measures of disease involvement included age at onset of the disease manifestations, hepatic and splenic volumes, age at splenectomy, and severity of bony disease. Highly statistically significant differences (P < .005) were found in each clinical parameter in patients with the N370S/N370S genotype compared with those patients with the N370S/84GG, N370S/L444P, and N370S/? genotypes. The symptomatic N370S homozygotes had onset of their disease two to three decades later than patients with the other genotypes. In addition, patients with the latter genotypes have much more severely involved livers, spleens, and bones and had a higher incidence of splenectomy at an earlier age. These predictive genotype analyses provide the basis for genetic care delivery and therapeutic recommendations in patients affected with Gaucher disease type 1.

Full text

PDF
1094

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barton N. W., Brady R. O., Dambrosia J. M., Di Bisceglie A. M., Doppelt S. H., Hill S. C., Mankin H. J., Murray G. J., Parker R. I., Argoff C. E. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med. 1991 May 23;324(21):1464–1470. doi: 10.1056/NEJM199105233242104. [DOI] [PubMed] [Google Scholar]
  2. Beighton P., Goldblatt J., Sacks S. Bone involvement in Gaucher disease. Prog Clin Biol Res. 1982;95:107–129. [PubMed] [Google Scholar]
  3. Beutler E. Gaucher's disease. N Engl J Med. 1991 Nov 7;325(19):1354–1360. doi: 10.1056/NEJM199111073251906. [DOI] [PubMed] [Google Scholar]
  4. Beutler E., Gelbart T., Kuhl W., Sorge J., West C. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10544–10547. doi: 10.1073/pnas.88.23.10544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beutler E., Gelbart T., Kuhl W., Zimran A., West C. Mutations in Jewish patients with Gaucher disease. Blood. 1992 Apr 1;79(7):1662–1666. [PubMed] [Google Scholar]
  6. Beutler E., Gelbart T., West C. The facile detection of the nt 1226 mutation of glucocerebrosidase by 'mismatched' PCR. Clin Chim Acta. 1990 Dec 24;194(2-3):161–166. doi: 10.1016/0009-8981(90)90130-k. [DOI] [PubMed] [Google Scholar]
  7. Beutler E., Kay A., Saven A., Garver P., Thurston D., Dawson A., Rosenbloom B. Enzyme replacement therapy for Gaucher disease. Blood. 1991 Sep 1;78(5):1183–1189. [PubMed] [Google Scholar]
  8. Choy F. Y., Woo M., Der Kaloustian V. M. Molecular analysis of Gaucher disease: screening of patients in the Montreal/Quebec region. Am J Med Genet. 1991 Dec 15;41(4):469–474. doi: 10.1002/ajmg.1320410418. [DOI] [PubMed] [Google Scholar]
  9. Erikson A., Groth C. G., Månsson J. E., Percy A., Ringdén O., Svennerholm L. Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type. Acta Paediatr Scand. 1990 Jun-Jul;79(6-7):680–685. doi: 10.1111/j.1651-2227.1990.tb11535.x. [DOI] [PubMed] [Google Scholar]
  10. Fallet S., Grace M. E., Sibille A., Mendelson D. S., Shapiro R. S., Hermann G., Grabowski G. A. Enzyme augmentation in moderate to life-threatening Gaucher disease. Pediatr Res. 1992 May;31(5):496–502. doi: 10.1203/00006450-199205000-00018. [DOI] [PubMed] [Google Scholar]
  11. Firon N., Eyal N., Kolodny E. H., Horowitz M. Genotype assignment in Gaucher disease by selective amplification of the active glucocerebrosidase gene. Am J Hum Genet. 1990 Mar;46(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  12. Glew R. H., Basu A., LaMarco K. L., Prence E. M. Mammalian glucocerebrosidase: implications for Gaucher's disease. Lab Invest. 1988 Jan;58(1):5–25. [PubMed] [Google Scholar]
  13. Grabowski G. A., Gatt S., Horowitz M. Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol. 1990;25(6):385–414. doi: 10.3109/10409239009090616. [DOI] [PubMed] [Google Scholar]
  14. Grabowski G. A., Goldblatt J., Dinur T., Kruse J., Svennerholm L., Gatt S., Desnick R. J. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Am J Med Genet. 1985 Jul;21(3):529–549. doi: 10.1002/ajmg.1320210316. [DOI] [PubMed] [Google Scholar]
  15. Grace M. E., Berg A., He G. S., Goldberg L., Horowitz M., Grabowski G. A. Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes. Am J Hum Genet. 1991 Sep;49(3):646–655. [PMC free article] [PubMed] [Google Scholar]
  16. Grace M. E., Graves P. N., Smith F. I., Grabowski G. A. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations. J Biol Chem. 1990 Apr 25;265(12):6827–6835. [PubMed] [Google Scholar]
  17. He G. S., Grabowski G. A. Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA. Am J Hum Genet. 1992 Oct;51(4):810–820. [PMC free article] [PubMed] [Google Scholar]
  18. Hermann G., Goldblatt J., Levy R. N., Goldsmith S. J., Desnick R. J., Grabowski G. A. Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy. AJR Am J Roentgenol. 1986 Nov;147(5):943–948. doi: 10.2214/ajr.147.5.943. [DOI] [PubMed] [Google Scholar]
  19. Hong C. M., Ohashi T., Yu X. J., Weiler S., Barranger J. A. Sequence of two alleles responsible for Gaucher disease. DNA Cell Biol. 1990 May;9(4):233–241. doi: 10.1089/dna.1990.9.233. [DOI] [PubMed] [Google Scholar]
  20. Latham T. E., Theophilus B. D., Grabowski G. A., Smith F. I. Heterogeneity of mutations in the acid beta-glucosidase gene of Gaucher disease patients. DNA Cell Biol. 1991 Jan-Feb;10(1):15–21. doi: 10.1089/dna.1991.10.15. [DOI] [PubMed] [Google Scholar]
  21. Latham T., Grabowski G. A., Theophilus B. D., Smith F. I. Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet. 1990 Jul;47(1):79–86. [PMC free article] [PubMed] [Google Scholar]
  22. Lee R. E. The pathology of Gaucher disease. Prog Clin Biol Res. 1982;95:177–217. [PubMed] [Google Scholar]
  23. Masuno M., Tomatsu S., Sukegawa K., Orii T. Non-existence of a tight association between a 444leucine to proline mutation and phenotypes of Gaucher disease: high frequency of a NciI polymorphism in the non-neuronopathic form. Hum Genet. 1990 Jan;84(2):203–206. doi: 10.1007/BF00208943. [DOI] [PubMed] [Google Scholar]
  24. Ohashi T., Hong C. M., Weiler S., Tomich J. M., Aerts J. M., Tager J. M., Barranger J. A. Characterization of human glucocerebrosidase from different mutant alleles. J Biol Chem. 1991 Feb 25;266(6):3661–3667. [PubMed] [Google Scholar]
  25. Sidransky E., Tsuji S., Martin B. M., Stubblefield B., Ginns E. I. DNA mutation analysis of Gaucher patients. Am J Med Genet. 1992 Feb 1;42(3):331–336. doi: 10.1002/ajmg.1320420315. [DOI] [PubMed] [Google Scholar]
  26. Starer F., Sargent J. D., Hobbs J. R. Regression of the radiological changes of Gaucher's disease following bone marrow transplantation. Br J Radiol. 1987 Dec;60(720):1189–1195. doi: 10.1259/0007-1285-60-720-1189. [DOI] [PubMed] [Google Scholar]
  27. Tarao K., Hoshino H., Motohashi I., Iimori K., Tamai S., Ito Y., Takagi S., Oikawa Y., Unayama S., Fujiwara T. Changes in liver and spleen volume in alcoholic liver fibrosis of man. Hepatology. 1989 Apr;9(4):589–593. doi: 10.1002/hep.1840090413. [DOI] [PubMed] [Google Scholar]
  28. Theophilus B. D., Latham T., Grabowski G. A., Smith F. I. Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid beta-glucosidase gene. Nucleic Acids Res. 1989 Oct 11;17(19):7707–7722. doi: 10.1093/nar/17.19.7707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Theophilus B., Latham T., Grabowski G. A., Smith F. I. Gaucher disease: molecular heterogeneity and phenotype-genotype correlations. Am J Hum Genet. 1989 Aug;45(2):212–225. [PMC free article] [PubMed] [Google Scholar]
  30. Tsai P., Lipton J. M., Sahdev I., Najfeld V., Rankin L. R., Slyper A. H., Ludman M., Grabowski G. A. Allogenic bone marrow transplantation in severe Gaucher disease. Pediatr Res. 1992 May;31(5):503–507. doi: 10.1203/00006450-199205000-00019. [DOI] [PubMed] [Google Scholar]
  31. Tsuji S., Choudary P. V., Martin B. M., Stubblefield B. K., Mayor J. A., Barranger J. A., Ginns E. I. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med. 1987 Mar 5;316(10):570–575. doi: 10.1056/NEJM198703053161002. [DOI] [PubMed] [Google Scholar]
  32. Tsuji S., Martin B. M., Barranger J. A., Stubblefield B. K., LaMarca M. E., Ginns E. I. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2349–2352. doi: 10.1073/pnas.85.7.2349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zimran A., Gelbart T., Westwood B., Grabowski G. A., Beutler E. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet. 1991 Oct;49(4):855–859. [PMC free article] [PubMed] [Google Scholar]
  34. Zimran A., Sorge J., Gross E., Kubitz M., West C., Beutler E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet. 1989 Aug 12;2(8659):349–352. doi: 10.1016/s0140-6736(89)90536-9. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES